GEN News: Drug promotes nervous system repair in animal models of stroke
Genetic Engineering & Biotechnology News recently featured research from the University of Cincinnati's Agnes (Yu) Luo, PhD.
Luo and her colleagues recently published a preclinical study in the journal Cell Reports showing a new drug may help repair damage caused by strokes. The drug was shown to be effective at repairing the nervous system in animal models of stroke.
“We are very excited about the data showing significant improvement in motor function, sensory function, spatial learning, and memory, even when treatment was initiated as late as seven days after stroke onset,” said Luo, associate professor in the Department of Molecular Genetics and Biochemistry in UC’s College of Medicine and the study’s senior author.
There are currently no FDA approved drugs to repair damage caused by a stroke, and Luo said the drug would be a “substantial breakthrough” if the early results translate into clinical settings.
Read more about Luo's research.
Featured photo at top courtesy of Unsplash.
Related Stories
UC launches Bearcats Affordability Grant
January 7, 2026
The University of Cincinnati is making college more attainable for students across Ohio with the creation of the Bearcats Affordability Grant. The new grant will provide a pathway to tuition-free college for students of families who make less than $75,000 per year. Beginning in fall 2026, the Bearcats Affordability Grant will cover the remaining cost of tuition for Ohio residents who are Pell eligible.
BearcatGPT AI platform now available to all UC faculty and staff
December 9, 2025
University of Cincinnati Digital Technology Solutions is excited to announce that BearcatGPT, the university’s private, secure AI platform, is now available to all UC faculty and staff.
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.